9 Meters Biopharma, Inc. Receives Orphan Drug Designation for NM-003, a Proprietary Long-Acting GLP-2, for Prevention of Acute Graft Versus Host Disease (aGvHD)
Go back to 9 Meters Biopharma, Inc. Receives Orphan Drug Designation for NM-003, a Proprietary Long-Acting GLP-2, for Prevention of Acute Graft Versus Host Disease (aGvHD)| New York Mortgage Trust, Inc. (NASDAQ: NMTR) | Delayed: 0.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.07 | 52 Week High | $2.69 | |||
| Open | $1.21 | 52 Week Low | $2.69 | |||
| Day High | $0.07 | P/E | 0.00 | |||
| Day Low | $0.07 | EPS | $-15.23 | |||
| Volume | 7,058,332 | |||||
